Compare IDEXX Laboratories, Inc. (IDXX) vs Centrus Energy Corp (LEU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Centrus Energy Corp — how do they compare? IDEXX Laboratories, Inc. trades at $518.98 (market cap $40.43B), while Centrus Energy Corp trades at $144.23 (market cap $2.91B). The key difference: IDEXX Laboratories, Inc. is far larger — about 13.9× Centrus Energy Corp's market cap, and Centrus Energy Corp is more actively traded (903,777 versus 692,164). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Centrus Energy Corp for 29 Days on average.
| IDXX | LEU | |
|---|---|---|
Market Cap | $40.43B | $2.91B |
Volume | 692,164 | 903,777 |
Sector | Health | Energy |
52-Week High | $766.68 | $436.00 |
52-Week Low | $504.70 | $138.18 |
Typical Hold Time | 46 Days | 29 Days |
Enterprise Value | $41.32B | $2.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Centrus Energy (LEU) trades at $141.28, down 3.98% on the day, with a bearish technical outlook despite recent earnings beats. The stock shows elevated valuation metrics (P/E 75.18, P/S 6.68) but benefits from strong nuclear energy tailwinds and multiple HALEU supply contracts. Recent news highlights Centrus as a key player in the domestic nuclear fuel supply chain, with analyst consensus pointing to significant upside potential from current levels.
The investment case balances high execution risk against substantial growth opportunities in nuclear fuel enrichment. While profitability metrics show pressure (net margin declining to 10.23%), the company's strategic positioning in HALEU production and federal support create compelling long-term potential. Key risks include operational execution, valuation sensitivity, and nuclear industry adoption timelines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →
